ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ADRB2 |
P07550
|
adrenoceptor beta 2
|
G-protein coupled receptor
|
0.53 |
0.442 |
0.923 |
AGER |
Q15109
|
advanced glycosylation end-product specific receptor
|
Receptor
|
6.4E-16 |
0.420 |
0.885 |
AHR |
P35869
|
aryl hydrocarbon receptor
|
Transcription factor
|
1.00 |
0.410 |
0.923 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
BECN1 |
Q14457
|
beclin 1
|
Enzyme modulator
|
0.94 |
0.432 |
0.846 |
CALCR |
P30988
|
calcitonin receptor
|
G-protein coupled receptor
|
3.1E-09 |
0.464 |
0.846 |
CAT |
P04040
|
catalase
|
Enzyme
|
1.6E-10 |
0.359 |
0.962 |
CCR4 |
P51679
|
C-C motif chemokine receptor 4
|
G-protein coupled receptor
|
6.9E-02 |
0.510 |
0.731 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CD46 |
P15529
|
CD46 molecule
|
|
4.7E-07 |
0.477 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CEACAM5 |
P06731
|
CEA cell adhesion molecule 5
|
|
4.2E-10 |
0.420 |
0.846 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
EGR1 |
P18146
|
early growth response 1
|
Nucleic acid binding
|
0.35 |
0.433 |
0.923 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
ESR1 |
P03372
|
estrogen receptor 1
|
Nuclear receptor
|
1.00 |
0.324 |
0.962 |